A preliminary analysis of data from 33 patients has already revealed a numerical trend towards higher prevalence of treatment failure driven by persistent bacteremia for the patients who had MRSA-BSIs caused by strains with vancomycin MIC ≥2 μg/ml.
← all excerpts
469The Relationship between Vancomycin Minimum Inhibitory Concentrations (MICs) and Treatment Failure among Patients with Methicillin-Resistant Staphylococcus aureus Blood Stream Infections (MRSA-BSI) at the University of Connecticut Health Center (UCHC)
1
—
—